Rhythm Pharmaceuticals: JPMorgan cuts target price to $142 from $145
RYTM•JPMorgan cut its target price for Rhythm Pharmaceuticals to $142 from $145.
Related News
AI's reality check
QQQ•
Stocks tumble as AI panic sweeps markets, bonds draw haven demand
SPY•
Workiva Inc.: Baird cuts target price to $95 from $105
WK•
Shinhan Financial Group to attend Samsung Securities investor conference
SHG•
DDC Enterprise plans 13.5% perpetual preferred share offering at $20 per share
DDC•